Eva van Ingen
- Name
- Dr. E. van Ingen
- e.van.ingen@lacdr.leidenuniv.nl
- Science
- Leiden Academic Centre for Drug Research
- LACDR/Biopharmaceutics
Contact
- Smit V., Mol J. de, Schaftenaar F.H., Depuydt M.A.C., Postel R.J., Smeets D.: Verheijen F.W.M., Bogers L., Duijn J. van, Verwilligen R.A.F., Grievink H.W., Bernabé Kleijn M.N.A., Ingen E. van, Jong M.J.M. de, Goncalves L.: Peeters J.A.H.M., Smeets H.J., Wezel A., Polansky J.K., Winther M.P.J. de, Binder C.J., Tsiantoulas D., Bot I., Kuiper J. & Foks A.C. (2023), Single-cell profiling reveals age-associated immunity in atherosclerosis, Cardiovascular Research 119(15): 2508-2521.
- Ingen E. van (9 June 2022), Small regulatory RNAs in vascular remodeling and atherosclerosis (PhD thesis, Faculty of Medicine, Leiden University Medical Center (LUMC), Leiden University). Supervisor(s) and Co-supervisor(s): Quax P.H.A., Nossent A.Y.
- Ingen E. van, Foks A.C.: Woudenberg T., Bent M.L. van der, Jong A. de, Hohensinner P.J., Wojta J., Bot I., Quax P.H.A. & Nossent A.Y. (2021), Inhibition of microRNA-494-3p activates Wntsignaling and reduces proinflammatorymacrophage polarization in atherosclerosis, Molecular Therapy - Nucleic Acids 26: 1228-1239.